AMB Volume 42, Issue 1, 2026 Pages 12-15 https://doi.org/10.59393/amb26420102
The R506Q (G1691A) Polymorphism in the Factor V Leiden Gene in Diabetic Nephropathy and Type 2 Diabetes Mellitus
Nikolov D., Nikolov G., Linev A., Geneva-Popova M., Popova-Belova S., Karusheva M., Iliev I.
Diabetic nephropathy is a leading microvascular complication of type 2 diabetes mellitus and a major cause of chronic kidney disease worldwide (Thomas et al., 2015; Alicic et al., 2017). In addition to metabolic and hemodynamic factors, genetic determinants may influence individual susceptibility and disease progression. The present study investigated the distribution of the R506Q (G1691A) polymorphism in the Factor V Leiden gene and its association with microalbuminuria dynamics in patients with type 2 diabetes mellitus and early diabetic nephropathy. Sixty-seven patients and thirty-eight healthy controls were included. Genomic DNA was extracted from peripheral blood leukocytes, and genotyping was performed using real-time PCR with allelic discrimination. Twenty-four-hour urinary albumin excretion was assessed at baseline and followed for 24 months. Heterozygous carriers were detected in 8.96% of patients. Carriers of the A allele demonstrated significantly slower progression of microalbuminuria compared with wild-type individuals (p < 0.05). The findings suggest that the R506Q polymorphism may act as a genetic modifier in the progression of diabetic nephropathy.
Keywords: Factor V Leiden, R506Q polymorphism, microalbuminuria, type 2 diabetes mellitus, diabetic nephropathy, real-time PCR
View Full Article